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Innate immune recognition is crucial for host responses against viral infections, including
infection by human immunodeﬁciency virus 1 (HIV-1). Human cells detect such invading
pathogens with a collection of pattern recognition receptors that activate the production
of antiviral proteins, such as the cytokine interferon-type I, to initiate antiviral responses
immediately as well as the adaptive immune response for long-term protection. To
establish infection in the host, many viruses have thus evolved strategies for subversion
of these mechanisms of innate immunity. For example, acute infection by HIV-1 and other
retroviruses have long been thought to be non-immunogenic, signifying suppression of
host defenses by these pathogens. Studies in the past few years have begun to uncover a
multifaceted scheme of how HIV-1 evades innate immune detection, especially of its DNA,
by exploiting host proteins. This review will discuss the host mechanisms of HIV-1 DNA
sensing and viral immune evasion, with a particular focus on TREX1, three prime repair
exonuclease 1, a host 3′ exonuclease (also known as DNase III).
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THE INTERFERON RESPONSE TO HIV DNA
Human immunodeﬁciency virus (HIV) enters T cells and
macrophages by ﬁrst interacting with host receptor CD4 then
with co-receptor chemokine (C-C motif) receptor 5 (CCR5) or
chemokine (C-X-C motif) receptor 4 (CXCR4) on the target cell
plasma membrane, triggering viral envelope fusion. HIV can also
bind to cell surface lectins (sugar-binding proteins) and enter cells
by endocytosis. This is the predominant mode of entry into den-
dritic cells (DCs), which play important roles in progression and
pathology of HIV infection (Luban, 2012; Manches et al., 2014),
although HIV-1 does not replicate efﬁciently in DCs. Regardless
of the mode of viral entry, the viral core containing its RNA is
released into the cytosol, and HIV-encoded reverse transcriptase
begins to convert viral RNA into DNA while still encapsulated in
the capsid core. After completion of reverse transcription, viral
integrase binds to both ends of full-length HIV-1 DNA to form
pre-integration complex, which delivers functional HIV DNA to
the host nucleus for chromosomal integration (Goff, 2007). Since
only a few copies of HIV DNA integrate, the bulk of HIV DNA
remains in the cytosol unless cleared by host enzymes (Yan et al.,
2010).
Although abundant, theHIV-encoded cytosolicDNAproduced
by reverse transcription does not trigger a cell-autonomous inter-
feron (IFN) or inﬂammatory response in activated CD4 T cells
and macrophages, its primary targets (Goldfeld et al., 1991; Yan
et al., 2010). HIV achieves immune evasion in these target cells
by exploiting the host DNase TREX1 (Yan et al., 2010), the most
abundant exonuclease inmammalian cell (Hoss et al., 1999; Mazur
and Perrino, 1999), to clear its DNA. This action of TREX1
diminishes HIV DNA products in the cytosol below the thresh-
old of immune activation. This is strikingly demonstrated in
Trex1−/− or knockdown cells. In the absence of TREX1, HIV
infection triggers a robust type I IFN response strictly dependent
upon the cytosolic DNA sensing pathway, including the endo-
plasmic reticulum (ER) localized adaptor stimulator of interferon
genes (STING), TANK-binding kinase 1 (TBK1), and the tran-
scription factor interferon regulatory factor 3 (IRF3) (Yan et al.,
2010). The HIV-stimulated IFN response in Trex1−/− cells can
be dampened by reverse transcriptase inhibitor (e.g., nevirapine)
but not by integrase inhibitor (e.g., raltegravir), consistent with
HIV DNA being the main pathogen associated molecular pat-
tern (PAMP) detected by an innate immune sensor (Yan et al.,
2010). The HIV DNA is sensed by binding to cGAMP synthase
(cGAS), which then synthesizes the unique second messenger din-
ucleotide cyclic GMP-AMP (cGAMP) that binds to STING to
activate downstream IFN signaling (Gao et al., 2013; Figure 1A).
This “competition” between TREX1 (proviral) and cGAS (antivi-
ral) for cytosolic DNA also applies to murine leukemia virus
(MLV) and simian immunodeﬁciency virus (SIV; Gao et al., 2013),
and likely many other retroviruses.
Thus, the absence of an immunogenic response to acute retro-
viral infection of target immune cells can be at least partially
explained by TREX1, which is ubiquitously expressed and at high
levels in immune cells (Pereira-Lopes et al., 2013), and may syn-
ergize with other host factors (see below). In one population
study comparing cohorts of healthy control andHIV-positive indi-
viduals, TREX1 polymorphisms associated with susceptibility to
HIV infection (Pontillo et al., 2013), although another study using
different cohorts of patients failed to detect such an association
(Sironi et al., 2012), suggesting that further investigation is needed
before genetic linkage is established. From an evolutionary stand-
point, it is intriguing that TREX1 is only found in mammals that
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FIGURE 1 | HIV-1 subversion of innate immune DNA sensing. (A) A
schematic diagram of early stages of HIV-1 life cycle. HIV-1 capsid (CA) and
associated host factors, CypA and CPSF6, regulate HIV DNA access to
innate immune sensing. TREX1 and SAMHD1 regulate HIV DNA quantity.
IN, integrase. (B) HIV-1 DNA sensing by cGAS in many target cells activates
a STING-mediated IFN response, whereas HIV-1 DNA sensing by IFI16 in
“bystander” quiescent CD4+T cells trigger IFN signaling, caspase-1
activation, IL-1β secretion and pyroptosis.
have co-evolved with retrovirus, suggesting that retroviruses have
adapted to exploit TREX1 for survival. Such an adaptation may
be particularly essential for HIV, which does not appear to encode
its own factors to antagonize intracellular innate immune sensing
systems like many other DNA and RNA viruses do. Indeed, these
ﬁndings have engendered a new paradigm for HIV-host inter-
actions – that HIV not only exploits many host factors for the
successful completion of the life cycle (Brass et al., 2008; König
et al., 2008), it also exploits several key host factors that are critical
for subversion of innate immune responses in target cells (Doitsh
et al., 2010, 2014; Manel et al., 2010; Yan et al., 2010).
PROINFLAMMATORY RESPONSE TO HIV DNA
HIV DNA can also trigger a proinﬂammatory response in non-
productively infected “bystander” CD4+ T cells and promote T
cell killing (Doitsh et al., 2010). HIV replication is restricted in
these “bystander”CD4+ T cells due to the action of SAM domain
andHDdomain containing protein 1 (SAMHD1) that depletes the
dNTP pool, as well as other unknown restrictive factors (Baldauf
et al., 2012). As a result, HIV replication in these cells arrests early
in the reverse transcription stage, although the limited amount
of DNA produced can be recognized by another cytosolic DNA
sensor interferon-induciable protein 16 (IFI16) (Monroe et al.,
2014; Figure 1B). IFI16 was initially identiﬁed as a sensor that
recognizes viral DNA or exogenous double-stranded DNA (intro-
duced by transfection) and signals via STING to activate the IFN
response (Unterholzner et al., 2010). A recent study found that
‘bystander” CD4+ T cells harboring abortive HIV DNA prod-
ucts trigger IFI16-mediated IFN signaling and inﬂammasome
response, including activation of caspase-1, secretion of IL-1β, and
death of the host cell by pyroptosis (Doitsh et al., 2014). This series
of discoveries reveals another exciting example of how HIV takes
advantage of DNA sensing as well as SAMHD1 restriction. In this
case, instead of avoiding DNA sensing, HIV stalls DNA replication
early in the reverse transcription stage to trigger inﬂammation and
cell death in “bystander” CD4+ T cells. Since CD4+ T cell deple-
tion is a highly diagnostic clinical feature of AIDS, these studies
raise an exciting possibility of reversing CD4+ T cell depletion
by blocking the inﬂammasome response with caspase-1 inhibitors
(Doitsh et al., 2014). Both cGAS and IFI16 sense HIV DNA, yet
they seem to function in distinct cell types and lead to different
consequences. Also, it was unclearwhyTREX1 is not able to inhibit
IFI16-mediated detection of HIV DNA. Further investigation is
needed to show what determines which innate immune signaling
pathway HIV DNA triggers or avoids, and how that inﬂuences the
overall ﬁtness of the virus.
QUANTITY CONTROL OF HIV DNA: TREX1 AND SAMHD1
As discussed above, the amount of HIV-1 DNA in the cytosol
depends upon the rates of synthesis and degradation by two
host factors (Figure 1A): TREX1 mediates HIV DNA degrada-
tion in several immune cell types, and SAMHD1 limits HIV-1
DNA synthesis by depleting the dNTP pool in resting CD4+
T cells as well as several other cell types of myeloid linage
(Hrecka et al., 2011; Laguette et al., 2011; Baldauf et al., 2012). In
DCs, SAMHD1 also prevents innate immune activation (Manel
et al., 2010; Sunseri et al., 2011). SAMHD1 restriction can be
overcome by treating cells with virus-like particles (VLPs) con-
taining the SAMHD1-antagnist protein Vpx, found in SIVmac
and HIV-2 viruses (Goujon et al., 2006). HIV-1, which does
not encode Vpx, Vpx-deﬁcient SIVmac, and HIV-2 all fail to
replicate efﬁciently in DCs (Hrecka et al., 2011; Laguette et al.,
2011). Detailed reviews on SAMHD1/Vpx can be found else-
where (Daugherty and Malik, 2012; Luban, 2012; Sze et al., 2013).
Here, we highlight features of SAMHD1 as in comparison with
TREX1.
TREX1 is expressed in most mammalian cell types (Pereira-
Lopes et al., 2013),whereas SAMHD1 expression ismore restricted
(Laguette et al., 2011). Since a defect in either enzyme triggers
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HIV-1 DNA sensing, they are thought to play non-redundant
roles. In cell culture, TREX1 deﬁciency leads to accumulation of
total HIV-1 DNA, but not integrated proviral DNA (Yan et al.,
2010). It therefore appears that TREX1 does not degrade full-
length integration-competent HIV-1 DNA, perhaps because it is
protected by integrase in the pre-integration complex. In contrast,
TREX1 appears able to degrade non-productive partial-length
DNA generated by error-prone reverse transcription that are not
incorporated into integrase complexes. This is consistent with
enzymatic properties of TREX1, a 3′ to 5′ exonuclease. Although
it has some activity toward any form of DNA, it is most efﬁ-
cient with single-stranded DNA or double-stranded DNA with
a single-stranded overhang (Mazur and Perrino, 1999). Conse-
quently, overall HIV-1 replication in which TREX1 expression is
suppressed or ablated is reduced compared replication in nor-
mal cells, because DNA sensing results in expression of antiviral
IFNs (Yan et al., 2010). In contrast, SAMHD1 depletion results in
increased HIV DNA synthesis, integration and overall replication
(Hrecka et al., 2011; Laguette et al., 2011). It appears confusing
at ﬁrst glance that although both TREX1 and SAMHD1 con-
trol the quantity of cytosolic HIV DNA, the overall outcome of
HIV-1 replication is quite the opposite. Also, both proteins atten-
uate autoimmunity, and patients carrying defective TREX1 or
SAMHD1 develop similar autoimmune and sterile inﬂammatory
phenotypes (Crow et al., 2006; Crow and Rehwinkel, 2009; Rice
et al., 2009). Therefore, important questions remain. Is the antivi-
ral role of SAMHD1 in HIV-1 pathogenesis in the complex human
immune setting different from current understanding of its role
as a restrictive factor? Has HIV-1 evolved to exploit SAMHD1
restriction to prevent replication in certain cell types, such as DCs,
in order to avoid cell-autonomous innate immune activation, or
to abort the reverse transcription stage in “bystander” CD4+ T
cells to activate inﬂammasomes and trigger pyroptosis?
Comparison of HIV-1 with HIV-2 offers some insights into
these questions. HIV-2 (containing Vpx) is far less pathogenic
compared to HIV-1 (lacking Vpx) in humans, so one possible
contributing factor to HIV-1 pathogenesis could be its inability to
antagonize SAMHD1or ability to avoid SAMHD1 expressing cells.
One should also consider other important differences between
HIV-1 and HIV-2, such as Vpu, which is only encoded by HIV-
1, that antagonizes restriction factor Tetherin (Neil et al., 2008).
Taken together, the opposing inﬂuences of TREX1 and SAMHD1
upon overall HIV-1 ﬁtness suggests that it will be important to
further evaluate these immunomodulators in combination as well
as in isolation in immune systems.
ACCESS CONTROL OF HIV DNA: CAPSID AND ASSOCIATED
HOST FACTORS
Aside from quantity, another factor in HIV-1 DNA sensing is
encapsulation of the DNA by the viral capsid, which encapsulates
the incoming genomic RNA and, later on, the reverse transcribed
DNA. It remains unclear whether or not the HIV-1 capsid core
disassembles during or after reverse transcription, and where in
the cell it occurs. In any case, capsid core uncoating and reverse
transcription are closely related. Several capsid assembly mutants
affect reverse transcription (Tang et al., 2001;Ambrose et al., 2012).
Conversely, inhibition of reverse transcription increases stability
of the HIV-1 capsid core (Yang et al., 2013). Therefore, stability of
the capsid core may play a role in HIV-1 DNA access or sensing.
In the case of MLV, the glycosylated Gag protein (glyco-Gag) from
the incoming virus enhances viral core stability and reduces DNA
sensing in TREX1 knock-down cells, so a similar relationship may
apply for HIV-1 (Stavrou et al., 2013). Moreover, host cofactor
proteins that bind the capsid also modulate sensing of cytosolic
HIV DNA. In one study (Lahaye et al., 2013), mutations of HIV-
1 and HIV-2 capsid proteins that enhance cyclophilin A (CypA)
binding triggered more robust DNA sensing in monocyte-derived
dendritic cells (MDDCs). In another study (Rasaiyaah et al., 2013),
mutations N74D and P90A in the HIV-1 capsid protein impaired
interaction with host factors cofactors cleavage and polyadeny-
lation speciﬁcity factor sub-unit 6 (CPSF6) and CypA, and also
promoted more DNA sensing in monocyte-derived macrophages
(MDMs). Although different cell types were examined, both stud-
ies revealed an unexpected new dimension in sensing of HIV DNA
by the host – access to the viral DNA dependent upon the viral
capsid and factors encoded by the host. It remains to be deter-
mined whether the incoming capsid core simply “shields” HIV
DNAfromcytosolic sensingmachinery byphysical or stericmeans,
or whether amore complexmechanismmight be in play that regu-
lates the dynamic connections of uncoating, reverse transcription,
and nuclear import.
SELF-DNA SENSING AND AUTOIMMUNE DISEASE
Remarkable similarity in clinical conditions between infectious
and autoimmune diseases has been recognized for many years.
And yet, molecular mechanisms are much better deﬁned in infec-
tious diseases, whereas cell-intrinsic causes of autoimmune disease
remain largely mysterious. TREX1 is an excellent example of a
protein that may bridge this gap in our knowledge by playing
important roles in both infectious and autoimmune diseases. In
addition to its role in innate immunity against HIV discussed
above, TREX1 is also a critical suppressor of self-recognition
that safeguards the host from erroneous autoimmune activa-
tion. Mutations in TREX1 in humans are associated with the
autoimmune and autoinﬂammatory disorders (Kavanagh et al.,
2008; Crow and Rehwinkel, 2009) Aicardi-Goutières syndrome
(AGS), familial chilblain lupus (FCL), systemic lupus erythemato-
sus (SLE), and retinal vasculopathy with cerebral leukodystrophy
(RVCL). In fact, TREX1 represents one of the highest mono-
genic linkages of SLE (Moser et al., 2009). Trex1–/– mice develop
multiple-organ inﬂammation, as well as autoantibodies, and suc-
cumb to inﬂammation burden early in age (Gall et al., 2012).
Self-DNA from endogenous retroelements (Stetson et al., 2008)
or DNA replication debris (Yang et al., 2007) are among the likely
causes of inﬂammation in Trex1–/– mice. Inﬂammatory pheno-
types can be rescued by eliminating essential components of the
known DNA sensing pathway (e.g., Irf3–/–, Sting–/–), function-
ally linking the DNase function of TREX1 to disease (Stetson et al.,
2008; Gall et al., 2012). Moreover, chemically modiﬁed self-DNA
that resists degradation by TREX1 can cause immune activation
even in the presence of TREX1. One example is oxidized DNA
that contains 8-hydroxyguanosin (8-OHG), which can be formed
in UV-exposed skin lesions or neutrophil extracellular traps (net-
works of extracellular ﬁbers composed of mostly DNA from
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neutrophils). The oxidized DNA elevates cGAS/STING-mediated
immune activation compared to unmodiﬁed DNA in a variety of
cell types (Gehrke et al., 2013).
TREX1: BEYOND DNase FUNCTION
TREX1 mutations that disrupt its DNase activity were mostly
found in AGS, and many disease-associated mutations of TREX1
do not affect its DNase activity, especially the ones associated
with SLE and RVCL (Lee-Kirsch et al., 2007; Richards et al., 2007).
TREX1 is a single exon gene that encodes an exonuclease domain at
its amino terminus, and an ER localization domain at its carboxyl
terminus. The ER localization domain consists of a hydrophilic
linker region of unknown function [although this region har-
bors many SLE mutations (Crow and Rehwinkel, 2009)] and
a small hydrophobic segment at the extreme carboxyl-terminus
that sorts TREX1 to the cytosolic leaﬂet of the ER membrane
by serving as an ER tail-anchor (rather than a classical trans-
membrane span; Lee-Kirsch et al., 2007; Lindahl et al., 2009).
In overexpression studies, the C-terminal domain of TREX1
mediated interaction with ubiquilin-1, leading to monoubiqui-
tination at multiple lysine residues of TREX1 (Orebaugh et al.,
2013). These modiﬁcations did not lead to TREX1 degrada-
tion, rather, they are possibly able to regulate TREX1 function
or localization (Hicke, 2001). Notably, several disease-causing
mutations of TREX1 exhibit altered ubiquitination patterns when
co-expressed with ubiquitin (Orebaugh et al., 2013), but do
not affect DNase activity. Clearly, the biological signiﬁcance
of monoubiquitination on native or disease-causing forms of
TREX1 for viral DNA sensing and autoimmunity requires further
investigation.
Abnormal accumulation of self-DNA likely promotes TREX1
AGS, since these alleles impair DNase activity, but the molecular
cause for TREX1 SLE that is strongly associated with mutations
in the C-terminal localization domain rather than the DNase
domain remains unclear. We recently found that TREX1-deﬁcient
cells have expanded lysosomal compartments, and that TREX1
deﬁciency promotes lysosomal biogenesis through mTORC1 and
transcription factor TFEB (Hasan et al., 2013). It remains to be
seen whether this new function of TREX1 is dependent upon its
DNase activity, and how it relates to various autoimmune diseases
associated with TREX1. Interestingly, although arising from the
same genetic locus, clinical conditions of TREX1 AGS and TREX1
SLE are highly distinct. TREX1 AGS mutations are autosomal
recessive. Patients develop severe neurological brain diseases with
excess IFNα in cerebral spinal ﬂuid resembling intrauterine infec-
tions, affecting mostly infant and young children, many of whom
die early in age (disease onset usually by 4 months; Kavanagh et al.,
2008). In contrast, TREX1 SLE mutations are mostly autosomal
dominant, with two exceptions where compound heterozygous
missense mutations were found (Lee-Kirsch et al., 2007). Unlike
TREX1 AGS, which is a pediatric disorder, TREX1 SLE disease
onset is usually between 15–40 years of age as is typical for lupus-
type autoimmune disorders. Similarly, TREX1 SLE patients have
high titers of a wide array of autoantibodies and IFN signa-
tures (Kavanagh et al., 2008). Despite some phenotypic overlap
between SLE and AGS, distinct disease mechanisms are therefore
likely.
CONCLUSIONS AND PERSPECTIVES
Extensive effort in the past two decades provided us with incred-
ible details on HIV-1 virology, life cycle, interactions with host
factors, and antagonism of host intrinsic restriction factors with
accessory proteins (Goff, 2007). In more recent years, with the
rapidly expanded understanding of innate immunity, studies have
begun to uncover mechanistic details of how HIV affects host
innate immunity (Luban, 2012). Like many other viruses, evasion
of host innate immunity is one of the most essential require-
ments for overall ﬁtness of HIV-1. However, what is remarkable
about HIV-1 compared to other DNA or RNA viruses is how it
achieves immune evasion by exploiting host proteins. Most DNA
or RNAviruses encode viral proteins that target speciﬁc intracellu-
lar innate immune sensing pathways involved in recognizing DNA
or RNA, or immune activation. HIV-1 does it by exploiting host
negative regulators of innate immunity to subvert sensing of its
own DNA. The focus of this review, DNase III/TREX1, normally
safeguards the host from autoimmune activation by self-DNA,
but is exploited by HIV-1 to evade sensing of its own DNA. In
a seemingly counterintuitive move, HIV-1 does not encode Vpx
that antagonizes a potent restriction factor SAMHD1. Interest-
ingly, vpx deletion during the evolution of SIVcpz (that eventually
gave rise to HIV-1) resulted in the creation of a unique vif that
can antagonize hominid restriction factor APOBEC3 (Etienne
et al., 2013). Whether this curious omission of Vpx contributes
to overall HIV-1 ﬁtness, and how much of that advantage is con-
tributed from SAMHD1, remain to be seen. This could be an
unprecedented way for a virus to subvert immune activation –
by keeping its replication low in professional IFN producing cells
such as DCs. Along the same line, abortive HIV DNA products
in bystander quiescent CD4+ T cells (due to the SAMHD1 block)
activate IFI16-mediated inﬂammasome response and pyroptosis –
an effective way to paralyze the host immune system.
These discoveries of unique HIV immune evasion strategies
may mark the beginning of an exciting new era on studies of HIV
innate immunity, with important new avenues to be explored.
Further studies in this emerging ﬁeld will certainly open our eyes
on how HIV navigates the human innate immune system. This
knowledge could also be harnessed for novel strategies of HIV
vaccine design that speciﬁcally target HIV immune evasion. We
look forward to seeing these studies unfold.
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